Jennifer Leslie

Jennifer Leslie is an accomplished professional in medical affairs and scientific communications, currently serving as the Executive Director of Medical Affairs at Kyverna Therapeutics since May 2023, after a tenure as Senior Director of Medical Affairs. Previously, Jennifer held the position of Director of Medical Communications at Ascendis Pharma and served in various roles at Vaniam Group, including Executive Director of Scientific Communications. With extensive experience in therapeutic areas such as hematology, CNS, and metastatic breast cancer, Jennifer has a strong background in medical communications, encompassing manuscript development, strategic publication planning, and advisory board management. Additionally, Jennifer's academic credentials include a Ph.D. in Biology from the Massachusetts Institute of Technology and dual B.S. degrees in Biology and Biochemistry from the University of Virginia.